HESTER BIOSCIENCES
Back to Balance Sheet
|
HESTER BIOSCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹8.81 Cr | ₹5.93 Cr | ₹7.41 Cr | ₹7.35 Cr | ₹6.51 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of HESTER BIOSCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹8.81 Cr |
| Mar2025 | ₹5.93 Cr |
| Mar2024 | ₹7.41 Cr |
| Mar2023 | ₹7.35 Cr |
| Mar2022 | ₹6.51 Cr |
How is Deferred Tax Assets / Liabilities of HESTER BIOSCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8.81 Cr | 48.46 | |
| Mar2025 | ₹5.93 Cr | -19.94 | |
| Mar2024 | ₹7.41 Cr | 0.82 | |
| Mar2023 | ₹7.35 Cr | 12.92 | |
| Mar2022 | ₹6.51 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,859.5 Cr | 1.4% | -0.2% | 9.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 1.4% |
-0.2% |
9.7% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses